ERBB2 and neoplasm: Combined with the results of previous results in this paper, it can be concluded that the C1 SRSF7+ MCs and tumor cells crosstalk through the AREG-EGFR/AREG-(EGFR+ERBB2) signal pathway, thereby exerting a tumor-promoting effect.